Beam Therapeutics Inc. is a biotechnology company that develops precision genetic medicines using their proprietary base editing technology. Their innovative CRISPR technology aims to edit disease-causing genetic mutations at the DNA level, potentially offering a revolutionary approach to treat a wide range of genetic diseases.
